Citadel Advisors’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6720 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6705 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6577 |
|
|
2024
Q2 | – | Sell |
-8,561
| Closed | -$20.3K | – | 6598 |
|
|
2024
Q1 | $20.3K | Sell |
8,561
-20,057
| -70% | -$47.5K | ﹤0.01% | 5547 |
|
|
2023
Q4 | $61.8K | Sell |
28,618
-6,766
| -19% | -$14.6K | ﹤0.01% | 5048 |
|
|
2023
Q3 | $74.3K | Sell |
35,384
-29,524
| -45% | -$62K | ﹤0.01% | 4945 |
|
|
2023
Q2 | $186K | Sell |
64,908
-11,103
| -15% | -$31.8K | ﹤0.01% | 4494 |
|
|
2023
Q1 | $221K | Buy |
76,011
+58,508
| +334% | +$170K | ﹤0.01% | 4548 |
|
|
2022
Q4 | $51.1K | Buy |
+17,503
| New | +$51.1K | ﹤0.01% | 5279 |
|
|
2022
Q3 | – | Sell |
-31,696
| Closed | -$72K | – | 6498 |
|
|
2022
Q2 | $72K | Buy |
+31,696
| New | +$72K | ﹤0.01% | 5404 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6932 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6988 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6925 |
|